LEGALDIGMLEGALDIGM
    ← Code of Federal Regulations
    Beta
    21 CFR § 316.28

    21 CFR § 316.28 — § 316.28 Publication of orphan-drug designations.

    Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.

    Analyze this law with AI
    § 316.28 Publication of orphan-drug designations. Each month FDA will update a publicly available cumulative posting of all drugs designated as orphan drugs. These postings will contain the following information: (a) The name and address of the sponsor; (b) The generic name and trade name, if any, or, if neither is available, the chemical name or a meaningful descriptive name of the drug; (c) The date of the granting of orphan-drug designation; (d) The designated use in the rare disease or condition; and (e) If the drug loses designation after August 12, 2013, the date of it no longer having designation. [78 FR 35134, June 12, 2013]

    Related guides, FAQ and contract templates